A Phase II Open-Label Study of Bermekimab in Patients with Hidradenitis Suppurativa Shows Resolution of Inflammatory Lesions and Pain

202088 citationsJournal Article

Authors

Good health and well-being

Published in: Journal of Investigative Dermatology

Volume 140, Issue 8, pp. 1538-1545.e2

Field-Weighted Citation Impact: 8.58